Exercise Program for Cognitive Decline
(MOVE Trial)
Trial Summary
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on antipsychotic medications or being treated for serious psychiatric disorders like Alzheimer's or dementia.
Research shows that sticking to an exercise program can improve some aspects of cognitive function in older adults with mild cognitive impairment. However, maintaining regular exercise is challenging, and strategies like goal setting, reminders, and enjoyable activities can help improve adherence.
12345Exercise programs, including those for cognitive decline, are generally safe for humans. Studies show that regular exercise can reduce risks of heart disease, diabetes, and improve overall health in older adults, with no significant adverse events reported in the context of cognitive impairment.
16789The Exercise Adherence Program is unique because it uses behavioral strategies to help people with memory loss stick to an exercise routine, breaking exercises into small, easy-to-remember steps and using memory aids to support adherence. This approach is different from other treatments that may not focus on overcoming memory-related barriers to exercise.
15101112Eligibility Criteria
This trial is for Black individuals aged 45-65 who may be experiencing mild cognitive impairment or dementia. It aims to test a goals-based exercise program developed with the help of the Black community to improve physical activity and potentially reduce cognitive decline.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessments including demographics, mental status, identity, and physical activity levels
Intervention
Participants engage in a goals-based exercise program with varying intensities and goal difficulties
Follow-up
Participants are monitored for exercise adherence, benefits, and barriers post-intervention